Most drugs aimed at Alzheimer’s and Parkinson’s disease try to slow the damage. A small team at Japan’s Shibaura Institute of ...
Researchers created Compound 10 to block GRK2 enzyme aggregation and protect mitochondria in Alzheimer's disease.
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Silvio Di Castro, Senior Technology Scientist at AstraZeneca, about his research, as well as the role of compound ...